Browse by Author

Article

Rastogi, N., Baker, S., Man, S., Uger, R., Wong, M., Coles, Steven ORCID: https://orcid.org/0000-0002-1109-6971, Hodges, M., Gilkes, A., Knapper, S., Darley, R. and Tonks, A. (2021) Use of an anti-CD200 blocking antibody improves immune responses to AML in vitro and in vivo. British Journal of Haematology, 193 (1). pp. 155-159. ISSN 1365-2141

Coles, Steven ORCID: https://orcid.org/0000-0002-1109-6971, Gilmour, M.N., Reed, R., Knapper, S., Burnett, A.K., Man, S., Tonks, A. and Darley, R.L. (2015) The Immunosuppressive Ligands PD-L1 and CD200 are Linked in AML T-cell Immunosuppression: Identification of a New Immunotherapeutic Synapse. Leukemia, 29 (9). pp. 1952-1954. ISSN Print: 0887-6924 Online: 1476-5551

Walsby, E.J., Coles, Steven ORCID: https://orcid.org/0000-0002-1109-6971, Knapper, S. and Burnett, A.K. (2011) The Topoisomerase II Inhibitor Voreloxin Causes Cell Cycle Arrest and Apoptosis in Myeloid Leukemia Cells and Acts in Synergy with Cytarabine. Haematologica, 96 (3). pp. 393-399. ISSN Print: 0390-6078 Online: 1592-8721

Conference or Workshop Item

Coles, Steven ORCID: https://orcid.org/0000-0002-1109-6971, Gilmour, M.N., Reid, R., Knapper, S., Burnett, A.K., Man, S., Tonks, A. and Darley, R.L. (2014) CD200 and PD1-L1 in AML Are Associated with Expanded PD-1+ Late Differentiated CD8+ T Cells and a Decreased CD4:CD8 Ratio: a New Link Between Distinct Immunosuppressive Pathways. In: 56th American Society of Hematology Annual Meeting and Exposition, 6th - 9th December 2014, San Francisco. (Unpublished)

Walsby, E.J., Coles, Steven ORCID: https://orcid.org/0000-0002-1109-6971, Knapper, S., Pepper, C. and Burnett, A.K. (2009) Topoisomerase II Inhibitor Voreloxin Causes Cell Cycle Arrest and Apoptosis in Acute Myeloid Leukaemia Cells and Acts in Synergy with Cytarabine. In: 51st American Society of Hematology (ASH) Annual Meeting and Exposition, 5th - 8th December 2009, New Orleans, LA, USA. (Unpublished)